ZIMMER BIOMET HOLDINGS, INC. (ZBH)
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 424,200 | 591,900 | 1,292,700 | 556,900 |
| Accounts receivable, less allowance for credit losses | 1,728,600 | 1,704,400 | 1,598,300 | 1,611,300 |
| Inventories | 2,246,800 | 2,286,400 | 2,483,700 | 2,454,200 |
| Prepaid expenses and other current assets | 562,900 | 537,300 | 460,300 | 431,400 |
| Total current assets | 4,962,500 | 5,119,900 | 5,834,900 | 5,053,900 |
| Property, plant and equipment, gross | 7,304,600 | 7,257,400 | 7,222,200 | 7,145,500 |
| Accumulated depreciation | 5,092,900 | 5,050,300 | 5,027,900 | 4,969,800 |
| Property, plant and equipment, net | 2,211,700 | 2,207,100 | 2,194,300 | 2,175,700 |
| Goodwill | 9,931,800 | 9,947,100 | 9,702,000 | 9,709,500 |
| Gross carrying amount | NaN | 10,378,900 | NaN | NaN |
| Technology Based Intangible Assets | NaN | 2,322,500 | NaN | NaN |
| Intellectual Property | NaN | 383,200 | NaN | NaN |
| Trademarks And Trade Names | NaN | 349,600 | NaN | NaN |
| Customer Relationships | NaN | 3,110,700 | NaN | NaN |
| Other Intangible Assets | NaN | 171,000 | NaN | NaN |
| Accumulated amortization | NaN | 6,337,000 | NaN | NaN |
| Gross carrying amount | NaN | 675,400 | NaN | NaN |
| Intangible assets, net | 4,547,600 | 4,717,300 | 4,739,700 | 4,890,800 |
| Other assets | 1,067,900 | 1,100,300 | 1,017,200 | 1,035,200 |
| Total assets | 22,721,600 | 23,091,700 | 23,488,000 | 22,865,100 |
| Accounts payable | 361,200 | 303,000 | 315,300 | 348,700 |
| Salaries, wages and benefits | 293,900 | NaN | NaN | NaN |
| Other current liabilities | 1,033,300 | 1,693,600 | 1,487,600 | 1,530,800 |
| Current portion of long-term debt | 1,175,900 | 587,100 | 600,000 | 820,000 |
| Total current liabilities | 2,864,300 | 2,583,700 | 2,402,900 | 2,699,500 |
| Deferred income taxes, net | 249,900 | 244,100 | NaN | NaN |
| Other long-term liabilities | 630,700 | 626,100 | 806,400 | 878,800 |
| Long-term debt | 6,295,100 | 6,932,000 | 7,512,600 | 6,752,500 |
| Total liabilities | 10,040,000 | 10,386,000 | 10,722,000 | 10,330,800 |
| Common stock, 0.01 par value, one billion shares authorized, 319.3 million shares as of march 31, 2026 (318.7 million as of december 31, 2025) issued | 3,200 | 3,200 | 3,200 | 3,200 |
| Paid-in capital | 10,199,300 | 10,178,600 | 10,155,500 | 10,108,100 |
| Retained earnings | 11,802,500 | 11,611,000 | 11,518,600 | 11,335,200 |
| Accumulated other comprehensive loss | -190,400 | -205,700 | -283,800 | -284,500 |
| Treasury stock, 125.9 million shares as of march 31, 2026 (123.2 million as of december 31, 2025) | 9,141,300 | 8,889,400 | 8,637,000 | 8,637,000 |
| Total zimmer biomet holdings, inc. stockholders' equity | 12,673,300 | 12,697,700 | 12,756,500 | 12,525,000 |
| Noncontrolling interest | 8,200 | 8,100 | 9,500 | 9,300 |
| Total stockholders' equity | 12,681,600 | 12,705,800 | 12,766,000 | 12,534,300 |
| Total liabilities and stockholders' equity | 22,721,600 | 23,091,700 | 23,488,000 | 22,865,100 |